Male Breast Cancer Completed Phase 1 Trials for Bavituximab (DB05136)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01288261Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast CancerTreatment